Table 1.
Basic clinical characteristics of patients
Characteristics | EGFR-TKI group | Chemotherapy group | Chemotherapy–EGFR-TKI group |
---|---|---|---|
| |||
Age (years) | |||
Median | 55 (37–77) | 53 (36–76) | 57 (36–79) |
Gender | |||
Female | 18 | 20 | 19 |
Male | 13 | 9 | 13 |
Smoking status | |||
Non-smoker | 18 | 24 | 27 |
Smokera | 13 | 5 | 5 |
ECOG score | |||
0–1 | 24 | 18 | 28 |
2–3 | 7 | 11 | 4 |
Stage of disease | |||
IIIB | 4 | 4 | 5 |
IV | 27 | 25 | 27 |
Histological subtype | |||
Adenocarcinoma | 30 | 24 | 30 |
Non-adenocarcinoma | 1 | 5 | 2 |
Mutation types | |||
Exon 19 | 18 | 11 | 20 |
Exon 21 | 12 | 11 | 10 |
Others | 1 | 7 | 2 |
Note:
A person who smoked more than 100 cigarettes in his/her past history was defined as an ever smoker.
Abbreviations: ECOG, Eastern Cooperative Oncology Group; TKI, tyrosine kinase inhibitor.